Oxford Nanopore Technologies plc (LON: ONT)
London
· Delayed Price · Currency is GBP · Price in GBp| Market Cap | 1.17B |
| Revenue (ttm) | 167.75M |
| Net Income (ttm) | -159.06M |
| Shares Out | 954.11M |
| EPS (ttm) | -0.19 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,112,467 |
| Open | 124.50 |
| Previous Close | 122.40 |
| Day's Range | 120.80 - 124.70 |
| 52-Week Range | 85.00 - 212.59 |
| Beta | 0.80 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Dec 4, 2024 |
About ONT
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five Min... [Read more]
Financial Performance
In 2023, ONT's revenue was 169.67 million, a decrease of -14.57% compared to the previous year's 198.60 million. Losses were -154.51 million, 69.7% more than in 2022.
Financial StatementsNews
UK health agencies join with Oxford Nanopore to speed up pathogen screening
Initiative is part of growing international efforts to give early warning of pandemic threats
Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a landmark strategic partnership with the UK ...
Half Year 2024 Oxford Nanopore Technologies PLC Earnings Presentation Transcript
Half Year 2024 Oxford Nanopore Technologies PLC Earnings Presentation Transcript
Oxford Nanopore reports 1H results
Read about Oxford Nanopore's 1H revenue decline but reiterated full-year guidance, with an adjusted EBITDA loss due to rising operational expenses.
Oxford Nanopore Eyes FTSE 250 Inclusion to Widen Investor Base
Oxford Nanopore Technologies Plc, the DNA-sequencing firm whose shares have plunged since going public, is setting its sights on FTSE 250 index inclusion that would widen the pool of potential investo...
Oxford Nanopore Technologies plc (ONTTF) Q2 2024 Earnings Call Transcript
Oxford Nanopore Technologies plc 2024 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Oxford Nanopore Technologies plc in conjunction with their 2024 Q2 earnings call.
Oxford Nanopore Technologies and Plasmidsaurus Announce Strategic Collaboration to Advance Plasmid Sequencing
OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, th...
Oxford Nanopore Technologies (ONT) - Product Pipeline Analysis 2024
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Oxford Nanopore Technologies Plc (ONT) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. Oxf...
RenovaroCube to acquire 100% ownership of Cyclomics
Renovaro strengthens its position in cancer diagnostics with the acquisition of Cyclomics, leveraging their partnerships with Oxford Nanopore and Nvidia.
Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI...
Oxford Nanopore launches PromethION 2 Integrated into open early access
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its P...
Oxford Nanopore Technologies plc (ONTTF) Full Year 2023 Earnings Call Transcript
Oxford Nanopore GAAP EPS of $19.00p, revenue of £169.7M
Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump
Oxford Nanopore shares declined 33% due to slower growth, but positive prospects and unique product features offer potential. See more on ONTTF stock here.
Britain's Oxford Nanopore's shares sink after revenue warning
Shares in Britain's Oxford Nanopore dropped nearly 12% on Tuesday, after the sensing technology company issued a revenue warning, citing a slowdown in China and the Middle East, along with staggered p...
Oxford Nanopore sales hit by US semiconductor restrictions
Oxford Nanopore Technologies said it had seen disruption to its diagnostics businesses due to the US/China trade war and second-half sales growth was slower than expected in some areas Over 2023, rev...
Oxford Nanopore and WeNou Announce a Partnership to Develop and Commercialise the First Rapid and Portable Food Authenticity Sequencing Test to Detect Food Fraud
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) and WeNou, a company providing innovative services based on DNA analysis for the food and feed sectors, today announce ...
Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the nanopore-sequencing company delivering unparalleled rich genomic data insights, and Fabric Genomics, the leadi...
Three Quick Facts: Coca Cola, Oxford Nanopore, BP
Tony Cross picks three things to know about the markets, featuring Coca Cola, Oxford Nanopore, BP
Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing
OXFORD, United Kingdom--(BUSINESS WIRE)-- #genomics--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Sap...
Oxford Nanopore gets £70m investment from French in-vitro diagnostics partner
Oxford Nanopore Technologies PLC (LSE:ONT) has secured a £70 million investment from French in-vitro diagnostics (IVD) company bioMérieux, in exchange for a 3.5% stake. Family-owned bioMérieux said it...
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
ROCHESTER, Minn. & OXFORD, England--(BUSINESS WIRE)--Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today unveile...
The University of Queensland and Oxford Nanopore Technologies Team up to Accelerate Research Into Quality Control Testing for mRNA Vaccines
OXFORD, England & BRISBANE, Australia--(BUSINESS WIRE)--Researchers at The University of Queensland are harnessing the latest sequencing technology developed by UK-based biotech Oxford Nanopore Techno...
NIH Center for Alzheimer's and Related Dementias publication shows comprehensive, high accuracy sequencing approach, using new Oxford Nanopore sequencing chemistry
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore sequencing technology has been used by a team led by researchers at the National Institutes of Health Center for Alzheimer's and Related Dementias (CA...